Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 47 entries
Sorted by: Best Match Show Resources per page
Draft Genome Sequence of Vibrio parahaemolyticus VH3, Isolated from an Aquaculture Environment in Greece.

Genome announcements

Castillo D, Jun JW, D'Alvise P, Middelboe M, Gram L, Liu S, Katharios P.
PMID: 26139725
Genome Announc. 2015 Jul 02;3(4). doi: 10.1128/genomeA.00731-15.

Vibrio parahaemolyticus is an important foodborne pathogen responsible for gastroenteritis outbreaks globally. It has also been identified as an important pathogen in aquatic organisms. Here, we report a draft genome sequence of V. parahaemolyticus, strain VH3, isolated from farmed...

Cite
Castillo D, Jun JW, D'Alvise P, et al. Draft Genome Sequence of Vibrio parahaemolyticus VH3, Isolated from an Aquaculture Environment in Greece. Genome Announc. 2015;3(4)doi: 10.1128/genomeA.00731-15.
Castillo, D., Jun, J. W., D'Alvise, P., Middelboe, M., Gram, L., Liu, S., & Katharios, P. (2015). Draft Genome Sequence of Vibrio parahaemolyticus VH3, Isolated from an Aquaculture Environment in Greece. Genome announcements, 3(4), . https://doi.org/10.1128/genomeA.00731-15
Castillo, Daniel, et al. "Draft Genome Sequence of Vibrio parahaemolyticus VH3, Isolated from an Aquaculture Environment in Greece." Genome announcements vol. 3,4 (2015). doi: https://doi.org/10.1128/genomeA.00731-15
Castillo D, Jun JW, D'Alvise P, Middelboe M, Gram L, Liu S, Katharios P. Draft Genome Sequence of Vibrio parahaemolyticus VH3, Isolated from an Aquaculture Environment in Greece. Genome Announc. 2015 Jul 02;3(4). doi: 10.1128/genomeA.00731-15. PMID: 26139725; PMCID: PMC4490853.
Copy Download .nbib Format: NLM
Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies.

Brain sciences

Brogna C, Luigetti M, Norcia G, Scalise R, Ferrantini G, Berti B, Romeo DM, Manna R, Mercuri E, Pane M.
PMID: 32156084
Brain Sci. 2020 Mar 07;10(3). doi: 10.3390/brainsci10030156.

We report the clinical case of a nine-year-old girl who presented with progressive motor neuropathy, revealed via the detection of a higher delay in F-wave recording using digitalized nerve conduction/electromyography. Since the lupus anticoagulant (LAC) positivity, detected using diluted...

Cite
Brogna C, Luigetti M, Norcia G, et al. Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies. Brain Sci. 2020;10(3)doi: 10.3390/brainsci10030156.
Brogna, C., Luigetti, M., Norcia, G., Scalise, R., Ferrantini, G., Berti, B., Romeo, D. M., Manna, R., Mercuri, E., & Pane, M. (2020). Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies. Brain sciences, 10(3), . https://doi.org/10.3390/brainsci10030156
Brogna, Claudia, et al. "Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies." Brain sciences vol. 10,3 (2020). doi: https://doi.org/10.3390/brainsci10030156
Brogna C, Luigetti M, Norcia G, Scalise R, Ferrantini G, Berti B, Romeo DM, Manna R, Mercuri E, Pane M. Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies. Brain Sci. 2020 Mar 07;10(3). doi: 10.3390/brainsci10030156. PMID: 32156084; PMCID: PMC7139660.
Copy Download .nbib Format: NLM
Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion.

Journal for immunotherapy of cancer

D'Alise AM, Leoni G, De Lucia M, Langone F, Nocchi L, Tucci FG, Micarelli E, Cotugno G, Troise F, Garzia I, Vitale R, Bignone V, Di Matteo E, Bartolomeo R, Charych DH, Lahm A, Zalevsky J, Nicosia A, Scarselli E.
PMID: 34824160
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003480.

BACKGROUND: A number of different immune pathways are involved in the effective killing of cancer cells, collectively named as the 'Cancer Immunity Cycle'. Anti-PD-1 checkpoint blockade (CPB) therapy is active on one of these pathways and reinvigorates anticancer T...

Cite
D'Alise AM, Leoni G, De Lucia M, et al. Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion. J Immunother Cancer. 2021;9(11)doi: 10.1136/jitc-2021-003480.
D'Alise, A. M., Leoni, G., De Lucia, M., Langone, F., Nocchi, L., Tucci, F. G., Micarelli, E., Cotugno, G., Troise, F., Garzia, I., Vitale, R., Bignone, V., Di Matteo, E., Bartolomeo, R., Charych, D. H., Lahm, A., Zalevsky, J., Nicosia, A., & Scarselli, E. (2021). Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion. Journal for immunotherapy of cancer, 9(11), . https://doi.org/10.1136/jitc-2021-003480
D'Alise, Anna Morena, et al. "Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion." Journal for immunotherapy of cancer vol. 9,11 (2021). doi: https://doi.org/10.1136/jitc-2021-003480
D'Alise AM, Leoni G, De Lucia M, Langone F, Nocchi L, Tucci FG, Micarelli E, Cotugno G, Troise F, Garzia I, Vitale R, Bignone V, Di Matteo E, Bartolomeo R, Charych DH, Lahm A, Zalevsky J, Nicosia A, Scarselli E. Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion. J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-003480. PMID: 34824160; PMCID: PMC8627409.
Copy Download .nbib Format: NLM
Selective dopaminergic effects on attention and memory in male mice exposed to Methylmercury during adolescence.

Neurotoxicology and teratology

Kendricks DR, Newland MC.
PMID: 34274440
Neurotoxicol Teratol. 2021 Sep-Oct;87:107016. doi: 10.1016/j.ntt.2021.107016. Epub 2021 Jul 16.

Gestational exposure to methylmercury disrupts dopamine-mediated behavior and produces heightened sensitivity to monoamine agonists later in life. This has been reported and replicated following both pre- and post-natal exposure. Impacts of methylmercury when exposure occurs during the sensitive period...

Cite
Kendricks DR, Newland MC. Selective dopaminergic effects on attention and memory in male mice exposed to Methylmercury during adolescence. Neurotoxicol Teratol. 2021;87:107016doi: 10.1016/j.ntt.2021.107016.
Kendricks, D. R., & Newland, M. C. (2021). Selective dopaminergic effects on attention and memory in male mice exposed to Methylmercury during adolescence. Neurotoxicology and teratology, 87107016. https://doi.org/10.1016/j.ntt.2021.107016
Kendricks, Dalisa R, and Newland, M Christopher. "Selective dopaminergic effects on attention and memory in male mice exposed to Methylmercury during adolescence." Neurotoxicology and teratology vol. 87 (2021): 107016. doi: https://doi.org/10.1016/j.ntt.2021.107016
Kendricks DR, Newland MC. Selective dopaminergic effects on attention and memory in male mice exposed to Methylmercury during adolescence. Neurotoxicol Teratol. 2021 Sep-Oct;87:107016. doi: 10.1016/j.ntt.2021.107016. Epub 2021 Jul 16. PMID: 34274440.
Copy Download .nbib Format: NLM
Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases.

Journal of clinical medicine

Ticci C, Orsucci D, Ardissone A, Bello L, Bertini E, Bonato I, Bruno C, Carelli V, Diodato D, Doccini S, Donati MA, Dosi C, Filosto M, Fiorillo C, La Morgia C, Lamperti C, Marchet S, Martinelli D, Minetti C, Moggio M, Mongini TE, Montano V, Moroni I, Musumeci O, Pancheri E, Pegoraro E, Primiano G, Procopio E, Rubegni A, Scalise R, Sciacco M, Servidei S, Siciliano G, Simoncini C, Tolomeo D, Tonin P, Toscano A, Tubili F, Mancuso M, Battini R, Santorelli FM.
PMID: 34065803
J Clin Med. 2021 May 12;10(10). doi: 10.3390/jcm10102063.

Movement disorders are increasingly being recognized as a manifestation of childhood-onset mitochondrial diseases (MDs). However, the spectrum and characteristics of these conditions have not been studied in detail in the context of a well-defined cohort of patients. We retrospectively...

Cite
Ticci C, Orsucci D, Ardissone A, et al. Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases. J Clin Med. 2021;10(10)doi: 10.3390/jcm10102063.
Ticci, C., Orsucci, D., Ardissone, A., Bello, L., Bertini, E., Bonato, I., Bruno, C., Carelli, V., Diodato, D., Doccini, S., Donati, M. A., Dosi, C., Filosto, M., Fiorillo, C., La Morgia, C., Lamperti, C., Marchet, S., Martinelli, D., Minetti, C., Moggio, M., Mongini, T. E., Montano, V., Moroni, I., Musumeci, O., Pancheri, E., Pegoraro, E., Primiano, G., Procopio, E., Rubegni, A., Scalise, R., Sciacco, M., Servidei, S., Siciliano, G., Simoncini, C., Tolomeo, D., Tonin, P., Toscano, A., Tubili, F., Mancuso, M., Battini, R., & Santorelli, F. M. (2021). Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases. Journal of clinical medicine, 10(10), . https://doi.org/10.3390/jcm10102063
Ticci, Chiara, et al. "Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases." Journal of clinical medicine vol. 10,10 (2021). doi: https://doi.org/10.3390/jcm10102063
Ticci C, Orsucci D, Ardissone A, Bello L, Bertini E, Bonato I, Bruno C, Carelli V, Diodato D, Doccini S, Donati MA, Dosi C, Filosto M, Fiorillo C, La Morgia C, Lamperti C, Marchet S, Martinelli D, Minetti C, Moggio M, Mongini TE, Montano V, Moroni I, Musumeci O, Pancheri E, Pegoraro E, Primiano G, Procopio E, Rubegni A, Scalise R, Sciacco M, Servidei S, Siciliano G, Simoncini C, Tolomeo D, Tonin P, Toscano A, Tubili F, Mancuso M, Battini R, Santorelli FM. Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases. J Clin Med. 2021 May 12;10(10). doi: 10.3390/jcm10102063. PMID: 34065803; PMCID: PMC8151313.
Copy Download .nbib Format: NLM
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment.

Molecular therapy oncolytics

De Lucia M, Cotugno G, Bignone V, Garzia I, Nocchi L, Langone F, Petrovic B, Sasso E, Pepe S, Froechlich G, Gentile C, Zambrano N, Campadelli-Fiume G, Nicosia A, Scarselli E, D'Alise AM.
PMID: 33209980
Mol Ther Oncolytics. 2020 Oct 14;19:253-264. doi: 10.1016/j.omto.2020.10.006. eCollection 2020 Dec 16.

Oncolytic viruses (OVs) are novel anti-tumor agents with the ability to selectively infect and kill tumor cells while sparing normal tissue. Beyond tumor cytolysis, OVs are capable of priming an anti-tumor immune response via lysis and cross-presentation of locally...

Cite
De Lucia M, Cotugno G, Bignone V, et al. Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment. Mol Ther Oncolytics. 2020;19:253-264doi: 10.1016/j.omto.2020.10.006.
De Lucia, M., Cotugno, G., Bignone, V., Garzia, I., Nocchi, L., Langone, F., Petrovic, B., Sasso, E., Pepe, S., Froechlich, G., Gentile, C., Zambrano, N., Campadelli-Fiume, G., Nicosia, A., Scarselli, E., & D'Alise, A. M. (2020). Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment. Molecular therapy oncolytics, 19253-264. https://doi.org/10.1016/j.omto.2020.10.006
De Lucia, Maria, et al. "Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment." Molecular therapy oncolytics vol. 19 (2020): 253-264. doi: https://doi.org/10.1016/j.omto.2020.10.006
De Lucia M, Cotugno G, Bignone V, Garzia I, Nocchi L, Langone F, Petrovic B, Sasso E, Pepe S, Froechlich G, Gentile C, Zambrano N, Campadelli-Fiume G, Nicosia A, Scarselli E, D'Alise AM. Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment. Mol Ther Oncolytics. 2020 Oct 14;19:253-264. doi: 10.1016/j.omto.2020.10.006. eCollection 2020 Dec 16. PMID: 33209980; PMCID: PMC7658578.
Copy Download .nbib Format: NLM
A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine.

Frontiers in neurology

Scalise R, Sgandurra G, Menici V, Capodagli N, Di Pietro R, Romeo DM, Sini F, Pagliano E, Foscan M, Cioni G, Battini R.
PMID: 33716922
Front Neurol. 2021 Feb 26;12:612429. doi: 10.3389/fneur.2021.612429. eCollection 2021.

Tetrabenazine has been studied with a variety of hyperkinetic movement disorders, but there is limited and empirical literature on the potential efficacy of tetrabenazine in children with dyskinetic cerebral palsy (DCP). The purpose of this study was to evaluate...

Cite
Scalise R, Sgandurra G, Menici V, et al. A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine. Front Neurol. 2021;12:612429doi: 10.3389/fneur.2021.612429.
Scalise, R., Sgandurra, G., Menici, V., Capodagli, N., Di Pietro, R., Romeo, D. M., Sini, F., Pagliano, E., Foscan, M., Cioni, G., & Battini, R. (2021). A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine. Frontiers in neurology, 12612429. https://doi.org/10.3389/fneur.2021.612429
Scalise, Roberta, et al. "A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine." Frontiers in neurology vol. 12 (2021): 612429. doi: https://doi.org/10.3389/fneur.2021.612429
Scalise R, Sgandurra G, Menici V, Capodagli N, Di Pietro R, Romeo DM, Sini F, Pagliano E, Foscan M, Cioni G, Battini R. A Retrospective Longitudinal Study in a Cohort of Children With Dyskinetic Cerebral Palsy Treated With Tetrabenazine. Front Neurol. 2021 Feb 26;12:612429. doi: 10.3389/fneur.2021.612429. eCollection 2021. PMID: 33716922; PMCID: PMC7953156.
Copy Download .nbib Format: NLM
How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective.

Frontiers in neurology

Azzollini V, Dalise S, Chisari C.
PMID: 35002937
Front Neurol. 2021 Dec 23;12:797559. doi: 10.3389/fneur.2021.797559. eCollection 2021.

Long-term disability caused by stroke is largely due to an impairment of motor function. The functional consequences after stroke are caused by central nervous system adaptations and modifications, but also by the peripheral skeletal muscle changes. The nervous and...

Cite
Azzollini V, Dalise S, Chisari C. How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective. Front Neurol. 2021;12:797559doi: 10.3389/fneur.2021.797559.
Azzollini, V., Dalise, S., & Chisari, C. (2021). How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective. Frontiers in neurology, 12797559. https://doi.org/10.3389/fneur.2021.797559
Azzollini, Valentina, et al. "How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective." Frontiers in neurology vol. 12 (2021): 797559. doi: https://doi.org/10.3389/fneur.2021.797559
Azzollini V, Dalise S, Chisari C. How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective. Front Neurol. 2021 Dec 23;12:797559. doi: 10.3389/fneur.2021.797559. eCollection 2021. PMID: 35002937; PMCID: PMC8733480.
Copy Download .nbib Format: NLM
How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective.

Frontiers in neurology

Azzollini V, Dalise S, Chisari C.
PMID: 35002937
Front Neurol. 2021 Dec 23;12:797559. doi: 10.3389/fneur.2021.797559. eCollection 2021.

Long-term disability caused by stroke is largely due to an impairment of motor function. The functional consequences after stroke are caused by central nervous system adaptations and modifications, but also by the peripheral skeletal muscle changes. The nervous and...

Cite
Azzollini V, Dalise S, Chisari C. How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective. Front Neurol. 2021;12:797559doi: 10.3389/fneur.2021.797559.
Azzollini, V., Dalise, S., & Chisari, C. (2021). How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective. Frontiers in neurology, 12797559. https://doi.org/10.3389/fneur.2021.797559
Azzollini, Valentina, et al. "How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective." Frontiers in neurology vol. 12 (2021): 797559. doi: https://doi.org/10.3389/fneur.2021.797559
Azzollini V, Dalise S, Chisari C. How Does Stroke Affect Skeletal Muscle? State of the Art and Rehabilitation Perspective. Front Neurol. 2021 Dec 23;12:797559. doi: 10.3389/fneur.2021.797559. eCollection 2021. PMID: 35002937; PMCID: PMC8733480.
Copy Download .nbib Format: NLM
Empiric ablation of polymorphic ventricular tachycardia/fibrillation in the absence of a mappable trigger: Prospective feasibility and efficacy of pacemap matching to defibrillator electrograms.

Heart rhythm

Salazar P, Beaser A, Upadhyay G, Aziz Z, Besser S, Shatz DY, Nayak H, Tung R.
PMID: 34757186
Heart Rhythm. 2021 Oct 30; doi: 10.1016/j.hrthm.2021.10.025. Epub 2021 Oct 30.

BACKGROUND: Catheter ablation strategies for ventricular fibrillation (VF) and polymorphic ventricular tachycardia (PMVT) are not established when spontaneous triggers are rare or absent.OBJECTIVE: The purpose of this study was to report the feasibility and efficacy of a novel empiric...

Cite
Salazar P, Beaser A, Upadhyay G, et al. Empiric ablation of polymorphic ventricular tachycardia/fibrillation in the absence of a mappable trigger: Prospective feasibility and efficacy of pacemap matching to defibrillator electrograms. Heart Rhythm. 2021;doi: 10.1016/j.hrthm.2021.10.025.
Salazar, P., Beaser, A., Upadhyay, G., Aziz, Z., Besser, S., Shatz, D. Y., Nayak, H., & Tung, R. (2021). Empiric ablation of polymorphic ventricular tachycardia/fibrillation in the absence of a mappable trigger: Prospective feasibility and efficacy of pacemap matching to defibrillator electrograms. Heart rhythm, . https://doi.org/10.1016/j.hrthm.2021.10.025
Salazar, Pablo, et al. "Empiric ablation of polymorphic ventricular tachycardia/fibrillation in the absence of a mappable trigger: Prospective feasibility and efficacy of pacemap matching to defibrillator electrograms." Heart rhythm vol. (2021). doi: https://doi.org/10.1016/j.hrthm.2021.10.025
Salazar P, Beaser A, Upadhyay G, Aziz Z, Besser S, Shatz DY, Nayak H, Tung R. Empiric ablation of polymorphic ventricular tachycardia/fibrillation in the absence of a mappable trigger: Prospective feasibility and efficacy of pacemap matching to defibrillator electrograms. Heart Rhythm. 2021 Oct 30; doi: 10.1016/j.hrthm.2021.10.025. Epub 2021 Oct 30. PMID: 34757186.
Copy Download .nbib Format: NLM
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells.

Cancers

Passariello M, Vetrei C, Sasso E, Froechlich G, Gentile C, D'Alise AM, Zambrano N, Scarselli E, Nicosia A, De Lorenzo C.
PMID: 32781690
Cancers (Basel). 2020 Aug 06;12(8). doi: 10.3390/cancers12082204.

The cytotoxic T lymphocyte-antigen 4 (CTLA-4) has been considered an IC exclusively expressed on T cells, where it counteracts the co-stimulatory CD28 receptor, by competing for its binding to CD-80 and CD-86. We recently found that it is expressed...

Cite
Passariello M, Vetrei C, Sasso E, et al. Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells. Cancers (Basel). 2020;12(8)doi: 10.3390/cancers12082204.
Passariello, M., Vetrei, C., Sasso, E., Froechlich, G., Gentile, C., D'Alise, A. M., Zambrano, N., Scarselli, E., Nicosia, A., & De Lorenzo, C. (2020). Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells. Cancers, 12(8), . https://doi.org/10.3390/cancers12082204
Passariello, Margherita, et al. "Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells." Cancers vol. 12,8 (2020). doi: https://doi.org/10.3390/cancers12082204
Passariello M, Vetrei C, Sasso E, Froechlich G, Gentile C, D'Alise AM, Zambrano N, Scarselli E, Nicosia A, De Lorenzo C. Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells. Cancers (Basel). 2020 Aug 06;12(8). doi: 10.3390/cancers12082204. PMID: 32781690; PMCID: PMC7464132.
Copy Download .nbib Format: NLM
Global occurrence and heterogeneity of the Roseobacter-clade species Ruegeria mobilis.

The ISME journal

Sonnenschein EC, Nielsen KF, D'Alvise P, Porsby CH, Melchiorsen J, Heilmann J, Kalatzis PG, López-Pérez M, Bunk B, Spröer C, Middelboe M, Gram L.
PMID: 28117449
ISME J. 2017 Feb;11(2):588. doi: 10.1038/ismej.2016.125.

No abstract available.

Cite
Sonnenschein EC, Nielsen KF, D'Alvise P, et al. Global occurrence and heterogeneity of the Roseobacter-clade species Ruegeria mobilis. ISME J. 2017;11(2):588doi: 10.1038/ismej.2016.125.
Sonnenschein, E. C., Nielsen, K. F., D'Alvise, P., Porsby, C. H., Melchiorsen, J., Heilmann, J., Kalatzis, P. G., López-Pérez, M., Bunk, B., Spröer, C., Middelboe, M., & Gram, L. (2017). Global occurrence and heterogeneity of the Roseobacter-clade species Ruegeria mobilis. The ISME journal, 11(2), 588. https://doi.org/10.1038/ismej.2016.125
Sonnenschein, Eva C, et al. "Global occurrence and heterogeneity of the Roseobacter-clade species Ruegeria mobilis." The ISME journal vol. 11,2 (2017): 588. doi: https://doi.org/10.1038/ismej.2016.125
Sonnenschein EC, Nielsen KF, D'Alvise P, Porsby CH, Melchiorsen J, Heilmann J, Kalatzis PG, López-Pérez M, Bunk B, Spröer C, Middelboe M, Gram L. Global occurrence and heterogeneity of the Roseobacter-clade species Ruegeria mobilis. ISME J. 2017 Feb;11(2):588. doi: 10.1038/ismej.2016.125. PMID: 28117449; PMCID: PMC5270566.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 47 entries